Vivos Therapeutics, Inc. - Common Stock

Aktie · US92859E2072 · VVOS (XNAS)

Übersicht

AI-gestützte Analyse

Fundamental-Analyse

Was die Zahlen wirklich bedeuten – bevor der Markt es weiß.

Jetzt analysieren

News Sentiment

Kaufchance oder Alarmsignal? Was die aktuellen Nachrichten wirklich bedeuten.

Jetzt analysieren

Kaufen / Halten / Verkaufen

Kaufen, Halten oder Verkaufen? Das AI-Urteil auf einen Blick.

Jetzt analysieren

Risiko-Bewertung

Risiken erkennen, bevor sie zum Problem werden.

Jetzt analysieren

Fair Value

Zu teuer, fair bewertet oder ein Schnäppchen?

Jetzt analysieren

Latest AI Analyses of Vivos Therapeutics, Inc. - Common Stock

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

29.04.2026 19:52

Current Prices from Vivos Therapeutics, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	VVOS	USD	29.04.2026 19:52	0,80 USD	-0,05 USD -5,89 %
IEX	VVOS	USD	29.04.2026 15:57	0,80 USD	-0,05 USD -5,82 %

Share Float & Liquidity

Free Float 54,21 %

Shares Float 3,19 M

Shares Outstanding 5,89 M

Company Profile for Vivos Therapeutics, Inc. - Common Stock Share

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.